• 1
    Kosmadaki, M.G. and Gilchrest, B.A. The demographics of aging in the United States: implications for dermatology. Arch. Dermatol. 138, 14271428 (2002).
  • 2
    Ranade, V.V. Drug delivery systems. 6. Transdermal drug delivery. J. Clin. Pharmacol. 31, 401418 (1991).
  • 3
    Buri, P., Puisieux, F., Doelker, E. and Benoit, J.P. Formes pharmaceutiques nouvelles. Technique et Documentation, Paris (1985).
  • 4
    Vecchia, B.E. and Bunge, A.L. Evaluating the transdermal permeability of chemicals. In: Transdermal Drug Delivery (electronic resource). (Guy, R.H. and Hadgraft, J. eds), pp. 2526. Dekker, New York (2003).
  • 5
    Guy, R.H. Current status and future prospects of transdermal drug delivery. Pharm. Res. 13, 17651769 (1996).
  • 6
    Roberts, M.S., Cross, S.E. and Pellett, M.A. Skin transport. In: Dermatological and Transdermal Formulations. (Walters, A.W., ed.), p. 121. Dekker, New York (2002).
  • 7
    Cullander, C. and Guy, R.H. Routes of delivery: case studies (6). Trasdermal delivery of peptides and proteins. Adv. Drug Deliv. Rev. 8, 291329 (1992).
  • 8
    Nakamura, R.M., Einck, L., Velmonte, M.A., Kawajiri, K., Ang, C.F., Delasllagas, C.E., Nacy, C.A. Detection of active tuberculosis by an MPB-64 transdermal patch: a field study. Scand. J. Infect. Dis. 33, 405407 (2001).
  • 9
    Pai, M., Kalantari, S. and Dheda, K. New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn. 6, 423432 (2006).
  • 10
    Billich, A., Aschauer, H., Aszodi, A. and Stuetz, A. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int. J. Pharm. 269, 2935 (2004).
  • 11
    Weiss, M., Fresneau, M., Monius, T., Stutz, A. and Billich, A. Binding of pimecrolimus and tacrolimus to skin and plasma proteins: Implications for systemic exposure after topical application. Drug Metab. Dispos. 36, 18121818 (2008).
  • 12
    Frech, S.A., Dupont, H.L., Bourgeois, A.L., McKenzie, R., Belkind-Gerson, J., Figueroa, J.F. et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 371, 20192025 (2008).
  • 13
    Billich, A., Vyplel, H., Grassberger, M., Schmook, F.P., Steck, A. and Stuetz, A. Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight. Bioorg. Med. Chem. 13, 31573167 (2005).
  • 14
    Smith, E.W. and Maibach, H.I. Percutaneous Penetration Enhancers, 2nd edn. Taylor and Francis Group, New York (2006).
  • 15
    Pillai, O. and Panchagnula, R. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J. Control Release 89, 127140 (2003).
  • 16
    Silva, R., Little, C., Ferreira, H. and Cavaco-Paulo, A. Incorporation of peptides in phospholipid aggregates using ultrasound. Ultrason. Sonochem. 15, 10261032 (2008).
  • 17
    Goebel, A. and Neubert, R.H. Dermal peptide delivery using colloidal carrier systems. Skin Pharmacol. Physiol. 21, 39 (2008).
  • 18
    Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M. et al. Transdermal protein delivery by a coadministered peptide identified via phage display. Nat. Biotechnol. 24, 455460 (2006).
  • 19
    Foldvari, M., Attah-Poku, S., Hu, J., Li, Q., Hughes, H., Babiuk, L.A. et al. Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery. J. Pharm. Sci. 87, 12031208 (1998).
  • 20
    Robinson, L.R., Fitzgerald, N.C., Doughty, D.G., Dawes, N.C., Berge, C.A. and Bissett, D.L. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int. J. Cosmet. Sci. 27, 155160 (2005).
  • 21
    Abdulghani, A.A., Sherr, A., Shirin, S., Solodkina, G., Morales Tapia, E., Wolf, B. et al. Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin. Dis. Manag. Clin. Outcomes 1, 136141 (1998).
  • 22
    Osborne, R., Robinson, L.R., Mullins, L. and Raleigh, P. Use of a facial moisturizer containing palmitoyl pentapeptide improves the appreance of aging skin J. Am. Acad. Dermatol. 52(3 Suppl 1):96 (2005).
  • 23
    Blanes-Mira, C., Clemente, J., Jodas, G., Gil, A., Fernandez-Ballester, G., Ponsati, B. et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int. J. Cosmet. Sci. 24, 303310 (2002).
  • 24
    Samuel, M., Brooke, R.C., Hollis, S. and Griffiths, C.E. Interventions for photodamaged skin. Cochrane Database Syst. Rev. CD001782 (2005).
  • 25
    Mazurowska, L. and Mojski, M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. J. Cosmet. Sci. 59, 5969 (2008).
  • 26
    Ruland, A., Kreuter, J. and Rytting, J.H. Transdermal delivery of the tetrapeptide hisetal (melanotropin (6-9)): II. Effect of various penetration enhancers. In vitro study across human skin. Int. J. Pharm. 103, 7780 (1994).
  • 27
    Ruland, A., Kreuter, J. and Rytting, J.H. Transdermal delivery of the tetrapeptide hisetal (melanotropin (6-9)). I. Effect of various penetration enhancers: In vitro study across hairless mouse skin. Int. J. Pharm. 101, 5761 (1994).
  • 28
    Mazurowska, L., Nowak-Buciak, K. and Mojski, M. ESI-MS method for in vitro investigation of skin penetration by copper-amino acid complexes: from an emulsion through a model membrane. Anal. Bioanal. Chem. 388, 11571163 (2007).
  • 29
    Ruland, A. and Kreuter, J. Transdermal permeability and skin accumulation of amino acids. Int. J. Pharm. 72, 149155 (1991).
  • 30
    Braun, E., Wagner, A., Furnschlief, E., Katinger, H. and Vorauer-Uhl, K. Experimental design for in vitro skin penetration study of liposomal superoxide dismutase. J. Pharm. Biomed. Anal. 40, 11871197 (2006).
  • 31
    Pickart, L. and Thaler, M.M. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat. New Biol. 243, 8587 (1973).
  • 32
    Maquart, F.X., Siméon, A., Pasco, S. and Monboisse, J.C. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J. Soc. Biol. 193, 423428 (1999).
  • 33
    Simeon, A., Wegrowski, Y., Bontemps, Y. and Maquart, F.X. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J. Invest. Dermatol. 115, 962968 (2000).
  • 34
    Simeon, A., Emonard, H., Hornebeck, W. and Maquart, F.X. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 67, 22572265 (2000).
  • 35
    Buffoni, F., Pino, R. and Dal Pozzo, A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch. Int. Pharmacodyn. Ther. 330, 345360 (1995).
  • 36
    Wegrowski, Y., Maquart, F.X. and Borel, J.P. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci. 51, 10491056 (1992).
  • 37
    Maquart, F.X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.C. and Borel, J.P. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 238, 343346 (1988).
  • 38
    Lintner, K. Promoting production in the extracellular matrix without compromising barrier. Cutis 70(6 Suppl):1316; discussion 21–3 (2002).
  • 39
    Croda USA. News and News Releases. Croda, Edison, NJ (1998).
  • 40
    Puig, A., Anton, J.M.G. and Mangues, M. A new decorin-like tetrapeptide for optimal organization of collagen fibres. Int. J. Cosmet. Sci. 30, 97104 (2008).
  • 41
    Dumas, M., Sadick, N.S., Noblesse, E., Juan, M., Lachmann-Weber, N., Boury-Jamot, M. et al. Hydrating skin by stimulating biosynthesis of aquaporins. J. Drugs Dermatol. 6(6 Suppl):s20s24 (2007).
  • 42
    Pauly, G., Contet-Audonneau, J., Moussou, P., Danoux, L., Bardey, V., Freis, O. et al. Small proteoglycans in the skin: New targets in the fight against aging. IFSCC 11, 2129 (2008).
  • 43
    Marikovsky, M., Breuing, K., Liu, P.Y., Eriksson, E., Higashiyama, S., Farber, P. et al. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl Acad. Sci. USA 90, 38893893 (1993).
  • 44
    Deplewski, D. and Rosenfield, R.L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 140, 40894094 (1999).
  • 45
    Cohen, I.K., Crossland, M.C., Garrett, A. and Diegelmann, R.F. Topical application of epidermal growth factor onto partial-thickness wounds in human volunteers does not enhance reepithelialization. Plast. Reconstr. Surg. 96, 251254 (1995).
  • 46
    Brown, G.L., Nanney, L.B., Griffen, J., Cramer, A.B., Yancey, J.M., Curtsinger Iii, L.J. et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med. 321, 7679 (1989).
  • 47
    Ghersetich, I., Comacchi, C. and Lotti, T. Immunohistochemical and ultrastructural investigation of multiple common warts before and after therapy with alpha-interferon. G. Ital. Dermatol. Venereol. 127, 207210 (1992).
  • 48
    Ghersetich, I. and Lotti, T. Alpha-interferon cream restores decreased levels of Langerhans/indeterminate (CD1a+) cells in aged and PUVA-treated skin. Skin Pharmacol. 7, 118120 (1994).
  • 49
    Frank, S., Madlener, M. and Werner, S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271, 1018810193 (1996).
  • 50
    Li, Y., Fan, J., Chen, M., Li, W. and Woodley, D.T. Transforming growth factor-alpha: A major human serum factor that promotes human keratinocyte migration. J. Invest. Dermatol. 126, 20962105 (2006).
  • 51
    Govinden, R. and Bhoola, K.D. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol. Ther. 98, 257265 (2003).
  • 52
    Ehrlich, M., Rao, J., Pabby, A. and Goldman, M.P. Improvement in the appearance of wrinkles with topical transforming growth factor beta (1) and l-ascorbic acid. Dermatol. Surg. 32, 618625 (2006).
  • 53
    Gold, M.H., Goldman, M.P. and Biron, J. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging. J. Drugs Dermatol. 6, 10181023 (2007).
  • 54
    Watson, R.E., Long, S.P., Bowden, J.J., Bastrilles, J.Y., Barton, S.P. and Griffiths, C.E. Repair of photoaged dermal matrix by topical application of a cosmetic ‘antiageing’ product. Br. J. Dermatol. 158, 472477 (2008).
  • 55
    Dal Farra, C., Bauza, E. and Domloge, N. Heat shock proteins for cosmeceuticals. In: Cosmeceuticals and Active Cosmetics. (Elsner, P. and Maibach, H.I., eds), pp. 523536. Marcel Dekker, New York, NY (2005).
  • 56
    Botto, J., Cucumel, K., Dal Farra, C. and Domloge, N. Treatment of human cells with Hsp-70-rich yeast extract enhances cell thermotolerance and resistance to stress. J. Invest. Dermatol. 117, 452 (2001).
  • 57
    Cucumel, K., Botto, J., Bauza, E., Dal Farra, C., Roetto, R. and Domloge, N. Artemia Extract Induces Hsp70 in Human Cells and Enhances Cell Protection from Stress. J. Invest. Dermatol. 117, 454 (2001).
  • 58
    Domloge, N., Bauza, E., Cucumel, K., Peyronel, D. and Dal Farra, C. Artemia extract toward more extensive sun protection. Cosmet. Toiletries 2002, 6978 (2002).
  • 59
    Bauza, E., Dal Farra, C. and Domloge, N. Hsp70 induction by Artemia extract exhibits anti-inflammatory effect and down-regulates IL-1 and IL-8 synthesis in human HaCaT cells. J. Invest. Dermatol. 117, 415 (2001).
  • 60
    Mosser, D.D., Caron, A.W., Bourget, L., Denis-Larose, C. and Massie, B. Role of the human heat shock protein hsp70 in protection against stress- induced apoptosis. Mol. Cell. Biol. 17, 53175327 (1997).
  • 61
    Gabai, V.L., Meriin, A.B., Mosser, D.D., Caron, A.W., Rits, S., Shifrin, V.I. et al. Hsp70 prevents activation of stress kinases: A novel pathway of cellular thermotolerance. J. Biol. Chem. 272, 1803318037 (1997).
  • 62
    Gutsmann-Conrad, A., Heydari, A.R., You, S. and Richardson, A. The expression of heat shock protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects. Exp. Cell Res. 241, 404413 (1998).
  • 63
    Wu, B., Gu, M.J., Heydari, A.R. and Richardson, A. The effect of age on the synthesis of two heat shock proteins in the HSP70 family. J. Gerontol. 48, B50B56 (1993).
  • 64
    Blake, M.J., Fargnoli, J., Gershon, D. and Holbrook, N.J. Concomitant decline in heat-induced hyperthermia and HSP70 mRNA expression in aged rats. Am. J. Physiol: Regul. Integr. Compar. Physiol. 260, R663R667 (1991).
  • 65
    Pardue, S., Groshan, K., Raese, J.D. and Morrison-Bogorad, M. Hsp70 mRNA induction is reduced in neurons of aged rat hippocampus after thermal stress. Neurobiol. Aging 13, 661672 (1992).
  • 66
    Fargnoli, J., Kunisada, T., Fornace Jr, A.J., Schneider, E.L. and Holbrook, N.J. Decreased expression of heat shock protein 70 mRNA and protein after heat treatment in cells of aged rats. Proc. Natl Acad. Sci. USA 87, 846850 (1990).
  • 67
    Muramatsu, T., Hataoko, M., Tada, H., Shirai, T. and Ohnishi, T. Age-related decrease in the inductability of heat shock protein 72 in normal human skin. Br. J. Dermatol. 134, 10351038 (1996).
  • 68
    Cucumel, K., Dal Farra, C. and Domloge, N. Artemia extract “compensates” for age-related decrease of Hsp70 in skin. J. Invest. Dermatol. 119, 257 (2002).
  • 69
    Barba, C., Mendez, S., Roddick-Lanzilotta, A., Kelly, R., Parra, J.L. and Coderch, L. Wool peptide derivatives for hand care. J. Cosmet. Sci. 58, 99107 (2007).
  • 70
    Barba, C., Mendez, S., Roddick-Lanzilotta, A., Kelly, R., Parra, J.L. and Coderch, L. Cosmetic effectiveness of topically applied hydrolysed keratin peptides and lipids derived from wool. Skin Res. Technol. 14, 243248 (2008).
  • 71
    Dal Farra, C., Oberto, G., Berghi, A. and Domloge, N. An anti-aging effect on the lips and skin observed in in vivo studies on a new fibronectin-like peptide. J. Am. Acad. Dermatol. 56(2Suppl2):AB88 (2007).
  • 72
    Sudel, K.M., Venzke, K., Mielke, H., Breitenbach, U., Mundt, C., Jaspers, S. et al. Novel aspects of intrinsic and extrinsic aging of human skin: beneficial effects of soy extract. Photochem. Photobiol. 81, 581587 (2005).
  • 73
    Andre-Frei, V., Perrier, E., Augustin, C., Damour, O., Bordat, P., Schumann, K. et al. A comparison of biological activities of a new soya biopeptide studied in an in vitro skin equivalent model and human volunteers. Int. J. Cosmet. Sci. 21, 299311 (1999).
  • 74
    Sim, G.S., Lee, D.H., Kim, J.H., An, S.K., Choe, T.B., Kwon, T.J. et al. Black rice (Oryza sativa L. var. japonica) hydrolyzed peptides induce expression of hyaluronan synthase 2 gene in HaCaT keratinocytes. J. Microbiol. Biotechnol. 17, 271279 (2007).
  • 75
    Padamwar, M.N., Pawar, A.P., Daithankar, A.V. and Mahadik, K.R. Silk sericin as a moisturizer: an in vivo study. J. Cosmet. Dermatol. 4, 250257 (2005).
  • 76
    Daithankar, A.V., Padamwar, M.N., Pisal, S.S., Paradkar, A.R. and Mahadik, K.R. Moisturizing efficiency of silk protein hydrolysate: Silk fibroin. Indian J. Biotechnol. 4, 115121 (2005).
  • 77
    Zhaorigetu, S., Yanaka, N., Sasaki, M., Watanabe, H. and Kato, N. Inhibitory effects of silk protein, sericin on UVB-induced acute damage and tumor promotion by reducing oxidative stress in the skin of hairless mouse. J. Photochem. Photobiol. B Biol. 71, 1117 (2003).
  • 78
    Foran, P.G., Mohammed, N., Lisk, G.O., Nagwaney, S., Lawrence, G.W., Johnson, E. et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A: Basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem. 278, 13631371 (2003).
  • 79
    Gutierrez, L.M., Viniegra, S., Rueda, J., Ferrer-Montiel, A.V., Canaves, J.M. and Montal, M. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J. Biol. Chem. 272, 26342639 (1997).
  • 80
    Gutierrez, L.M., Canaves, J.M., Ferrer-Montiel, A.V., Reig, J.A., Montal, M. and Viniegra, S. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca2+-dependent exocytosis in chromaffin cells. FEBS Lett. 372, 3943 (1995).
  • 81
    Snyder, E.L. and Dowdy, S.F. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin. Drug Deliv. 2, 4351 (2005).
  • 82
    Hou, Y.W., Chan, M.H., Hsu, H.R., Liu, B.R., Chen, C.P., Chen, H.H. et al. Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides. Exp. Dermatol. 16, 9991006 (2007).
  • 83
    Choi, S.H., Kim, S.Y., An, J.J., Lee, S.H., Kim, D.W., Ryu, H.J. et al. Human PEP-1-ribosomal protein S3 protects against UV-induced skin cell death. FEBS Lett. 580, 67556762 (2006).
  • 84
    Morris, M.C., Depollier, J., Mery, J., Heitz, F. and Divita, G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 11731176 (2001).
  • 85
    Appa, Y., Stephens, T., Barkovic, S. and Finkey, M.B. A clinical evaluation of a copper-peptide-containing liquid foundation and cream concealer designed for improving skin condition. In: American Academy of Dermatology 60th Annual Meeting (Gaspan, A.A., Goldberg, L.H., Gupta, A.K. et al. , ed.), p. 28. American Academy of Dermatology, New Orleans, LA, USA (2002).
  • 86
    Leyden, J.J., Stevens, T., Finkey, M.B. and Barkovic, S. Skin care benefits of copper peptide containing facial cream. In: American Academy of Dermatology 60th Annual Meeting (Gaspari, A.A., Goldberg, L.H., Gupta, A.K. et al. , ed.), pp. 29, American Academy of Dermatology, New Orleans, LA, USA (2002).
  • 87
    Finkey, M.B., Appa, Y. and Bhandarkar, S. Copper peptide and skin. In: Cosmeceuticals and Active Cosmetics, 2nd edn (Elsner, P. and Maibach, H.I., eds), pp. 549564. Marcel Dekker, New York, NY (2005).
  • 88
    Leyden, J.J., Stevens, T., Finkey, M.B. and Barkovic, S. Skin care benefits of copper peptide containing eye creams. In: American Academy of Dermatology 60th Annual Meeting (Gaspari, A.A., Goldberg, L.H., Gupta, A.K. et al. , ed.), pp. 29, American Academy of Dermatology, New Orleans, LA, USA (2002).